REVENUE (Tables)

6 Months Ended

Jun. 30, 2021

Revenue from Contract with Customer [Abstract]

Disaggregated revenue

The following table represents disaggregated net product sales in the periods presented as follows (in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2021		2020		2021		2020
Net product sales:
EXPAREL / bupivacaine liposome injectable suspension	$	131,050	$	73,821	$	246,520	$	176,296
iovera°	3,813		1,395		7,081		3,665
Total net product sales	$	134,863	$	75,216	$	253,601	$	179,961